Can you provide the average price target for CLENE INC stock?
12 analysts have analysed CLNN and the average price target is 30.94 USD. This implies a price increase of 403.91% is expected in the next year compared to the current price of 6.14.
NASDAQ:CLNN • US1856342019
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CLENE INC (CLNN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-03-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-10 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-10 | Benchmark | Maintains | Buy -> Buy |
| 2025-08-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-30 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-08 | Benchmark | Maintains | Buy -> Buy |
| 2025-04-23 | Jones Trading | Initiate | Buy |
| 2025-04-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-24 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 654K 39.15% | 342K -47.71% | 200K -41.52% | 235.283K 17.64% | 46.155M 19,516.77% | 169.09M 266.35% | 306.15M 81.06% | 466.81M 52.48% | 633.75M 35.76% | 905.22M 42.84% | 1.239B 36.87% | |
| EBITDA YoY % growth | -38.835M 18.05% | -31.448M 19.02% | -21.588M 31.35% | -25.704M -19.07% | -32.283M -25.60% | 3.315M 110.27% | 149.02M 4,395.32% | 296.21M 98.77% | 565.79M 91.01% | 724.1M 27.98% | 821.2M 13.41% | |
| EBIT YoY % growth | -40.54M 16.26% | -33.093M 18.37% | -23.083M 30.25% | -29.617M -28.31% | -19.976M 32.55% | 117.45M 687.94% | 171.66M 46.16% | 280.07M 63.15% | 402.12M 43.58% | 548.41M 36.38% | 819.21M 49.38% | |
| Operating Margin | -6,198.78% | -9,676.32% | -11,541.50% | -12,587.68% | -43.28% | 69.46% | 56.07% | 60.00% | 63.45% | 60.58% | 66.12% | |
| EPS YoY % growth | -10.40 -13.04% | -5.94 42.88% | -2.60 56.23% | -2.10 19.38% | -1.43 31.87% | 3.05 313.75% | 3.88 27.15% | 7.49 93.04% | 12.78 70.59% | 17.58 37.55% | 20.80 18.31% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.63 -604.56% | -0.51 35.05% | -0.47 44.60% | -0.49 44.17% |
| Revenue Q2Q % growth | 41.412K -48.87% | 51.612K 91.16% | 61.812K 312.08% | 69.972K -9.13% |
| EBITDA Q2Q % growth | -5.457M -48.61% | -5.865M -15.14% | -6.579M -45.78% | -7.803M -30.05% |
| EBIT Q2Q % growth | -7.283M -78.68% | -7.563M -28.98% | -8.109M -43.58% | -9.06M -20.88% |
All data in USD
12 analysts have analysed CLNN and the average price target is 30.94 USD. This implies a price increase of 403.91% is expected in the next year compared to the current price of 6.14.
CLENE INC (CLNN) will report earnings on 2026-05-13.
The consensus EPS estimate for the next earnings of CLENE INC (CLNN) is -0.63 USD and the consensus revenue estimate is 41.41K USD.
The consensus rating for CLENE INC (CLNN) is 81.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.